Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Ginat

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Cureus|July 20, 2016
Unilateral Laminotomy with Bilateral Spinal Canal Decompression for Lumbar Stenosis: A Technical NoteMarc Moisi, Christian Fisahn, Lara Tkachenko, et al.
JAMA Network Open|April 13, 2022
Development and Validation of a Decision Analytical Model for Posttreatment Surveillance for Patients With Oropharyngeal CarcinomaVivek Nair, Samuel Auger, Sara Kochanny, et al.
Oral Oncology|October 18, 2021
Risk and response adapted de-intensified treatment for HPV-associated oropharyngeal cancer: Optima paradigm expanded experienceAri J Rosenberg, Nishant Agrawal, Alexander Pearson, et al.
Neurocritical Care|October 7, 2020
Cerebrovascular Complications in Early Survivors of Civilian Penetrating Brain InjuryAli Mansour, Andrea Loggini, Faten El Ammar, et al.
JAMA Oncology|March 6, 2025
Neoadjuvant Nivolumab Plus Chemotherapy Followed by Response-Stratified Chemoradiation Therapy in HPV-Negative Head and Neck Cancer: The DEPEND Phase 2 Nonrandomized Clinical TrialAri J Rosenberg, Aditya Juloori, Michael J Jelinek, et al.
BMC Cancer|January 4, 2022
Prospective study evaluating dynamic changes of cell-free HPV DNA in locoregional viral-associated oropharyngeal cancer treated with induction chemotherapy and response-adaptive treatmentAri J Rosenberg, Evgeny Izumchenko, Alexander Pearson, et al.
JAMA Oncology|June 6, 2024
Neoadjuvant Nivolumab Plus Chemotherapy Followed By Response-Adaptive Therapy for HPV+ Oropharyngeal Cancer: OPTIMA II Phase 2 Open-Label Nonrandomized Controlled TrialAri J Rosenberg, Nishant Agrawal, Aditya Juloori, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Cureus|July 20, 2016
Unilateral Laminotomy with Bilateral Spinal Canal Decompression for Lumbar Stenosis: A Technical NoteMarc Moisi, Christian Fisahn, Lara Tkachenko, et al.
JAMA Network Open|April 13, 2022
Development and Validation of a Decision Analytical Model for Posttreatment Surveillance for Patients With Oropharyngeal CarcinomaVivek Nair, Samuel Auger, Sara Kochanny, et al.
Oral Oncology|October 18, 2021
Risk and response adapted de-intensified treatment for HPV-associated oropharyngeal cancer: Optima paradigm expanded experienceAri J Rosenberg, Nishant Agrawal, Alexander Pearson, et al.
Neurocritical Care|October 7, 2020
Cerebrovascular Complications in Early Survivors of Civilian Penetrating Brain InjuryAli Mansour, Andrea Loggini, Faten El Ammar, et al.
JAMA Oncology|March 6, 2025
Neoadjuvant Nivolumab Plus Chemotherapy Followed by Response-Stratified Chemoradiation Therapy in HPV-Negative Head and Neck Cancer: The DEPEND Phase 2 Nonrandomized Clinical TrialAri J Rosenberg, Aditya Juloori, Michael J Jelinek, et al.
BMC Cancer|January 4, 2022
Prospective study evaluating dynamic changes of cell-free HPV DNA in locoregional viral-associated oropharyngeal cancer treated with induction chemotherapy and response-adaptive treatmentAri J Rosenberg, Evgeny Izumchenko, Alexander Pearson, et al.
JAMA Oncology|June 6, 2024
Neoadjuvant Nivolumab Plus Chemotherapy Followed By Response-Adaptive Therapy for HPV+ Oropharyngeal Cancer: OPTIMA II Phase 2 Open-Label Nonrandomized Controlled TrialAri J Rosenberg, Nishant Agrawal, Aditya Juloori, et al.
Pageof 3